side effects of getting off glp 1 Stopping GLP-1s: Weight Regain and Maintenance Tips Weaning off a GLP-1? Tips

There are also several ongoing clinical trials assessing the long-term effects of these medications, especially in pediatric patients

These alterations determine a predisposition to depressive symptoms or exacerbate existing mood disorders

Tirzepatide, on the other hand, is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist

Retatrutide is a synthetic peptide developed for metabolic and endocrine research involving obesity, glycemic control, and multiple metabolic pathways

In a Phase 2 trial, adults with obesity lost about 24% of their body weight after 48 weeks, the largest drop reported for this class so far

Monitor progress: Track your weight, appetite, and energy levels to see how your body responds